Cephalon Patent Suit Over Amrix Survives Dismissal
A federal judge has ruled that a patent infringement suit against Anchen Pharmaceuticals Inc. over its plans to make a generic version of Cephalon Inc. muscle relaxant Amrix can go forward,...To view the full article, register now.
Already a subscriber? Click here to view full article